Skip to content

An Evaluation the Effect of Superhydration Versus Dextrose 10% for Prevention of Post Operative Nausea and Vomiting After Laparoscopic Cholecystectomy (prospective Randomised Controlled Study)

Superhydration Versus Dextrose 10% for Prevention of Post Operative Nausea and Vomiting After Laparoscopic Cholecystectomy (prospective Randomised Controlled Study)

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06847594
Enrollment
204
Registered
2025-02-26
Start date
2024-02-25
Completion date
2024-10-10
Last updated
2025-02-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative Nausea and Vomiting (PONV)

Keywords

postoperative nausea and vomiting, nausea, vomiting, laparoscopic cholecystectomy, superhydration, glucose 10%, dextrose 10%

Brief summary

The goal of this clinical trial is to learn if Dextrose 10% or superhydration works to prevent postoperative nausea and vomiting in patients undergoing laparoscopic cholecystectomy. . The main questions it aims to answer are: Does Dextrose 10% or superhydration lower the number of times participants gets an episode of nausea and vomititng after laparoscopic cholecystectomy surgery? Researchers will compare Dextrose 10% versus superhydration to a placebo (a look-alike substance that contains no drug) to see if glucose 10% or superhydation can work to prevent postoperative nausea and vomiting. Participants will: Take Dextrose 10% or superhydration or a placebo in the operation monitored for 4 hours after surgery to check on their nausea and vomiting state

Interventions

DRUGringer lactate (20ml/kg)

ringer lactate 20 ml/kg over the first 90 to 120 minutes after induction intraoperatively

Dextrose 10% 250 ml over 60 minutes

Sponsors

Ain Shams University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
21 Years to 60 Years
Healthy volunteers
Yes

Inclusion criteria

1. Age: 21- 60 years 2. Patients with ASA classification I and II

Exclusion criteria

1. Declining to give written informed consent. 2. Patients with morbid obesity (BMI \> 40). 3. ASA classification III-V. 4. Sever hypertension and heart failure. 5. Significant hepatic or renal disorder. 6. Patients with diagnosed diabetes mellitus type 1 or type 2. 7. Patients with history of PONV currently receiving steroids or antiemetics. 8. Pregnant or menstruating patients.

Design outcomes

Primary

MeasureTime frame
To compare the incidence of Post operative nausea and vomiting in the study treatment groupsPostoperative 4 hours stay in PACU

Secondary

MeasureTime frameDescription
Frequency of vomiting episodesPostoperative 4 hours stay in PACU
Measurement of PONV severity scoresPostoperative 4 hours stay in PACUSeverity of PONV was assessed using a 4-point Verbal Descriptive Scale (VDS) which consists of: Score 0= no PONV: no complaint of nausea or vomiting; Score 1= mild PONV: patient complains from nausea but doesn't need antiemetic treatment. Score 2= moderate PONV: patient complains from nausea and need antiemetic treatment; Score 3= severe PONV: patient complains from nausea with episode of vomiting requiring antiemetic treatment. PONV scores were obtained every half hour
Time from extubation till discharge from PACUFrom the moment of extubation till the moment of discharge from PACU with patient being completely vitally stable and nausea and vomiting free , assessed to be from 4 to 8 hours
total antiemetic medication consumptionPostoperative period 4 hours stay in PACU. ( if the patient needed to stay for longer duration in the PACU for any medical reason then any antiemetic used in this period will be recorded as well )Severity of PONV was assessed using a 4-point Verbal Descriptive Scale (VDS) which consists of: Score 0= no PONV: no complaint of nausea or vomiting; Score 1= mild PONV: patient complains from nausea but doesn't need antiemetic treatment. Score 2= moderate PONV: patient complains from nausea and need antiemetic treatment; Score 3= severe PONV: patient complains from nausea with episode of vomiting requiring antiemetic treatment. PONV scores were obtained every half hour, Rescue antiemetic granisetron 1 mg IV was given when VDS scores were 2 or more. Medications were given only after excluding other causes of PONV such as hypovolemia, hypotension, hypoxia. The total number of doses of antiemetics used were obtained every half hour from the time of entry to the PACU for 4 hours

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026